Hepion Pharmaceuticals
HEPA
#10262
Rank
A$4.93 M
Marketcap
$0.45
Share price
-0.86%
Change (1 day)
-77.88%
Change (1 year)

Earnings for Hepion Pharmaceuticals (HEPA)

Earnings in 2024 (TTM): -A$44.65 Million

According to Hepion Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$77.18 Million a decrease over its 2022 earnings that were of -A$70.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hepion Pharmaceuticals from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$44.65 Million-42.15%
2023 -A$77.18 Million9.74%
2022 -A$70.33 Million37.49%
2021 -A$51.15 Million61.27%
2020 -A$31.72 Million174.55%
2019 -A$11.56 Million-31.28%
2018 -A$16.82 Million
2016 -A$33.37 Million6.03%
2015 -A$31.47 Million265%
2014 -A$8.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.23 Billion 375.25%๐Ÿ‡บ๐Ÿ‡ธ USA